Dakrory Ahmed I, Fahmy Sohair R, Soliman Amel M, Mohamed Ayman S, Amer Sayed A M
Biology Department, Faculty of Science, Taif University, Saudi Arabia ; Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Biomed Res Int. 2015;2015:563652. doi: 10.1155/2015/563652. Epub 2015 Mar 2.
Oxidative stress is a common mechanism contributing to the initiation and progression of hepatic damage. Hence there is a great demand for the development of agents with potent antioxidant effect. The aim of the present study is to evaluate the efficacy of Holothuria atra extract (HaE) as an antioxidant against 7,12-dimethylbenz[a]anthracene- (DMBA-) induced hepatorenal dysfunction. Experimental animals were divided into two main groups: protective and curative. Each group was then divided into five subgroups pre- or posttreated either with distilled water (DMBA subgroups) or with HaE (200 mg/kg body weight) for seven and fourteen days. Single oral administration of DMBA (15 mg/kg body weight) to Wistar rats resulted in a significant increase in the serum liver enzymes and kidney function's parameters. DMBA increased level of liver malondialdehyde (MDA), decreased levels of reduced glutathione (GSH), glutathione-S-transferase (GST), superoxide dismutase (SOD), and catalase (CAT) in the liver tissue, and induced liver histopathological alterations. Pre- or posttreatment with HaE orally for 14 days significantly reversed the hepatorenal alterations induced following DMBA administration. In conclusion, HaE exhibits good hepatoprotective, curative, and antioxidant potential against DMBA-induced hepatorenal dysfunction in rats that might be due to decreased free radical generation.
氧化应激是导致肝损伤发生和发展的常见机制。因此,开发具有强大抗氧化作用的药物具有很大的需求。本研究的目的是评估黑海参提取物(HaE)作为抗氧化剂对7,12-二甲基苯并[a]蒽(DMBA)诱导的肝肾损伤的疗效。实验动物分为两个主要组:保护组和治疗组。然后将每组再分为五个亚组,分别用蒸馏水(DMBA亚组)或HaE(200 mg/kg体重)进行预处理或后处理,持续7天和14天。对Wistar大鼠单次口服给予DMBA(15 mg/kg体重)导致血清肝酶和肾功能参数显著升高。DMBA增加了肝脏丙二醛(MDA)水平,降低了肝脏组织中还原型谷胱甘肽(GSH)、谷胱甘肽-S-转移酶(GST)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的水平,并诱导了肝脏组织病理学改变。口服HaE进行14天的预处理或后处理可显著逆转DMBA给药后引起的肝肾改变。总之,HaE对DMBA诱导的大鼠肝肾损伤具有良好的肝保护、治疗和抗氧化潜力,这可能是由于自由基生成减少所致。